Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANTOX and Magnesiocard in Hereditary and Idiopathic Chronic Pancreatitis
NCT00142233Phase 3Completed
- Sponsor
- Universitätsklinikum Greifswald
- Start
- Jun 2005
- Primary completion
- Sep 2019
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of Antox, magnesium l-aspartate hydrochloride trihydrate in hereditary pancreatitis (HP), Idiopathic Chronic Pancreatitis (ICP), sponsored by Universitätsklinikum Greifswald. Started Jun 2005; status: completed.
02
Drugs
Antoxmagnesium l-aspartate hydrochloride trihydrate
03
Conditions
hereditary pancreatitis (HP)Idiopathic Chronic Pancreatitis (ICP)
Beyond the preview
Go deeper on NCT00142233.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00142233.